Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Confronting one of the world’s greatest health challenges
Collaborative Ted Rogers Centre has taken new aim at heart failure
Ted Rogers Centre launches four years ago today
Marking the largest gift in Canadian health-care history
Astounding finding points to new therapeutic target for ARVC
How a routine blood test could flag type of cardiomyopathy
Introducing: ECHO
New initiative supports innovators of CV technologies
The best is yet to come
Download our first public report that details our ambitious mission
Novel idea to treat ATTR amyloidosis enters clinical trial
Novel idea to treat ATTR amyloidosis enters clinical trial
Loretta Rogers Chair in Immunobioengineering to study heart from unique angle
Our first Loretta Rogers Chair in Immunobioengineering
U of T health-care collaborations share $3.5 million in new federal funding
U of T health-care collaborations share $3.5 million in federal funding
Unveiling our first million dollar visionary projects
AI, stem cell approaches to address heart failure
Can this scavenger receptor help solve high cholesterol?
Can this scavenger receptor help solve high cholesterol?